cocaine and adamantane

cocaine has been researched along with adamantane in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asin, KE; Nikkel, AL; Wirtshafter, D1
Crespi, F1
Chausmer, AL; Katz, JL1
Crossman, AR; Kobylecki, C; Ravenscroft, P1
Golozoubova, V; Gotfredsen, CF; Knudsen, LB; Raun, K; Rolin, B; von Voss, P1

Other Studies

5 other study(ies) available for cocaine and adamantane

ArticleYear
Repeated D1 receptor agonist treatment blocks cocaine-induced locomotor activity and c-fos expression.
    Brain research, 1994, Feb-21, Volume: 637, Issue:1-2

    Topics: Adamantane; Animals; Benzopyrans; Cocaine; Dopamine Agents; Gene Expression; Genes, fos; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1

1994
The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats.
    Methods and findings in experimental and clinical pharmacology, 1998, Volume: 20, Issue:8

    Topics: Adamantane; Alcohol Drinking; Alcoholism; Animals; Benzodiazepinones; Cocaine; Cocaine-Related Disorders; Drinking; Male; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide

1998
Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
    Psychopharmacology, 2002, Volume: 159, Issue:2

    Topics: Adamantane; Animals; Benzazepines; Benzopyrans; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1

2002
Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
    Experimental neurology, 2013, Volume: 247

    Topics: Adamantane; Alternative Splicing; Animals; Antiparkinson Agents; Cocaine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Iodine Isotopes; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Sympatholytics

2013
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: Adamantane; Animals; Body Composition; Body Weight; Candy; Energy Intake; Energy Metabolism; Glucagon-Like Peptide 1; Hypoglycemic Agents; Liraglutide; Nitriles; Obesity; Pancreas; Pyrrolidines; Rats; Rats, Sprague-Dawley; Vildagliptin

2007